Skip to content
Catalyst

synephrineFinding

Synephrine has no detected effect on maximal fat oxidation rate (MFO)

no difference foundLimited evidenceFinding

01 · The sentence it was drawn from

“The intake of p-synephrine did not modify MFO (0.28 ± 0.08 vs. 0.26 ± 0.10 g/min, p = 0.449, d = 0.21, respectively) or Fatmax (44.6 ± 7.8 vs. 40.8 ± 8.6%, p = 0.096, d = 0.50, respectively) over the placebo condition.”
Quoted verbatim from Effect of p-Synephrine on Fat Oxidation Rate during Exercise of Increasing Intensity in Healthy Active Women.
This finding among the 2 findings on its endpoint

synephrine

Maximal fat oxidation rate (MFO)

no difference found

Who
18 healthy, recreationally active women, fasted, morning trials, one acute dose against a cellulose placebo in a randomised crossover; MFO taken from a ramp test on a cycle ergometer in 3-minute stages from 30% to 80% of VO2max
Dose studied
3 mg p-synephrine per kg body mass as synephrine HCl, single oral dose 60 min before the exercise test

Limited evidencePMID 36297036 · 2022

02 · The study

Study
crossover
Duration
not reported

Evidence, by strength

  • strong
  • moderate
  • limitedthis finding
  • very limited
  • insufficient

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M7ESZRREJGMFYTTBQPZBJVAA